What are Methylphenidate HCl Chewable Tablets?
A physician may have prescribed Methylphenidate Hydrochloride (HCl) Chewable Tablets to help you or your child with ADHD. Methylphenidate is a stimulant medication that has been prescribed for decades and has been very well-studied.1 It is one of the most widely used prescription stimulants for the treatment of ADHD.2 Methylphenidate provides relief from ADHD symptoms and helps improve behavior.2
Lupin's Methylphenidate HCl Chewable Tablets are a short-acting, immediate-release, chewable formulation that provide an appropriate option for patients who only need medication during certain parts of their day.1 Patients ages 6-18 may prefer the chewable formulation over others.3 And portable, precise dosing makes administration more convenient for those on the go.4
Methylphenidate HCl Chewable Tablets
Provide a choice of formulation that some patients ages 6-18 may prefer3
Convenient, precise dosing for those on the go4
AB-rated to Methylin®* (Methylphenidate HCl Chewable tablets)
How It Works – Chewable ADHD Medication
Children living with ADHD often have more difficulty paying attention or tend to be more impulsive or hyperactive compared with other children the same age.5 Methylphenidate HCl Chewable Tablets are a stimulant medication that, along with other corrective measures, can help to reduce some of the symptoms seen in ADHD, such as inattentiveness, hyperactivity and impulsivity.2,6 Because of the extensive evidence of efficacy and safety, stimulants are considered a first-choice medication for ADHD by the American Academy of Pediatrics.7
Physicians typically begin by prescribing low doses of stimulants and then increase the dose gradually until reaching a therapeutic effect.1 Stimulants like Methylphenidate HCl Chewable Tablets are prescription medications and should be taken under medical supervision and monitored by a physician. The American Academy of Pediatrics also recommends that medication be accompanied by behavior therapy, as studies have shown that this combination can result in using lower stimulant doses.8
*Methylin® is a registered trademark of Mallinckrodt LLC.
"ADHD Parents Medication Guide." American Academy of Child & Adolescent Psychiatry and American Psychiatric Association (2013).
"Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects." Lakhan, S and Kirchgessner, A. Brain and Behavior (2012), vol. 2, no. 5.
Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency. Reflection Paper: Formulations of Choice for the Paediatric Population (EMEA/CHMP/PEG/194810/2005).
"Safety of Chewable Tablets for Children." Michele Th., Knorr B., Vada E., Reiss Th. Journal of Asthma (2002), vol. 39, No. 5.
"Role of Aberrant Striatal DopamineD1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine." Napolitano, F. The Journal of Neuroscience (2010), vol. 30, no. 33.
"ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder." Connolly, J et al. Therapeutic Innovation & Regulatory Science (2015), vol. 49, no. 5.
"ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention- Deficit/Hyperactivity Disorder in Children and Adolescents." Pediatrics (2015), vol. 128 (Supplement).
"ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention- Deficit/Hyperactivity Disorder in Children and Adolescents." Pediatrics (2011), vol. 128, no. 5.